908 Devices Inc. (NASDAQ:MASS) Director Mark Spoto Purchases 2585 Shares – MarketBeat

This post was originally published on this site

908 Devices Inc. (NASDAQ:MASSGet Rating) Director Mark Spoto bought 2,585 shares of the stock in a transaction dated Tuesday, November 22nd. The shares were acquired at an average price of $9.65 per share, for a total transaction of $24,945.25. Following the completion of the purchase, the director now directly owns 40,423 shares in the company, valued at $390,081.95. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.

908 Devices Stock Performance

Shares of NASDAQ MASS traded up $0.52 during mid-day trading on Wednesday, reaching $10.10. 165,038 shares of the company’s stock were exchanged, compared to its average volume of 315,679. The firm has a market capitalization of $319.06 million, a price-to-earnings ratio of -10.89 and a beta of 0.47. 908 Devices Inc. has a 52 week low of $9.27 and a 52 week high of $28.45. The company has a debt-to-equity ratio of 0.08, a current ratio of 11.73 and a quick ratio of 11.12. The firm has a 50-day moving average price of $14.88 and a two-hundred day moving average price of $17.03.

Institutional Investors Weigh In On 908 Devices

A number of hedge funds have recently made changes to their positions in the business. Legal & General Group Plc raised its stake in shares of 908 Devices by 21.9% during the 2nd quarter. Legal & General Group Plc now owns 6,436 shares of the company’s stock worth $133,000 after purchasing an additional 1,157 shares during the period. Northern Trust Corp increased its holdings in 908 Devices by 0.7% in the 2nd quarter. Northern Trust Corp now owns 187,442 shares of the company’s stock worth $3,859,000 after acquiring an additional 1,389 shares during the last quarter. UBS Group AG increased its holdings in 908 Devices by 171.0% in the 3rd quarter. UBS Group AG now owns 2,439 shares of the company’s stock worth $40,000 after acquiring an additional 1,539 shares during the last quarter. Daiwa Securities Group Inc. increased its holdings in 908 Devices by 45.7% in the 1st quarter. Daiwa Securities Group Inc. now owns 4,983 shares of the company’s stock worth $95,000 after acquiring an additional 1,564 shares during the last quarter. Finally, Advisor Group Holdings Inc. increased its holdings in 908 Devices by 30.5% in the 1st quarter. Advisor Group Holdings Inc. now owns 7,467 shares of the company’s stock worth $142,000 after acquiring an additional 1,744 shares during the last quarter. 65.65% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, SVB Leerink lowered their target price on 908 Devices from $30.00 to $25.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 15th.

About 908 Devices

(Get Rating)

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider 908 Devices, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and 908 Devices wasn’t on the list.

While 908 Devices currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

This post was originally published on *this site*